CollPlant Ltd. (TASE:CLPT; OTC:CQPTY), a regenerative medicine company utilizing its proprietary plant-based rhCollagen technology for tissue repair products, announce that it has completed the recruitment of all 20 patients for its clinical trial  of Vergenix™FG (Flowable Gel), indicated for the